GeneNews Posts Decline in Q2 Revenues, Trims Loss | GenomeWeb

NEW YORK (GenomeWeb News) – GeneNews on Friday reported a 66 percent decline in second-quarter revenues but narrowed its loss compared to the year-ago period.

For the three months ended June 30, the Toronto-based diagnostics developer recorded revenue of C$100,000 (US$90,078) compared to C$300,000 (US$270,263) in the comparable period of 2008.

The company's net loss improved to C$1.8 million, or C$0.03 per common share, compared to C$4 million, or C$0.07 per common share for the second quarter of 2008.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.